chloramphenicol has been researched along with methotrexate in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (58.49) | 18.7374 |
| 1990's | 1 (1.89) | 18.2507 |
| 2000's | 9 (16.98) | 29.6817 |
| 2010's | 12 (22.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bera, S; Mondal, D | 1 |
| Brunk, CF; Yaffe, D | 1 |
| Eveloff, AR; Lascari, AD | 1 |
| Basu, TK | 1 |
| Bender, RA; Warren, RD | 1 |
| Gajcy, H | 1 |
| Hirota, Y | 1 |
| Dimnik, LS; Hoar, DI | 1 |
| Hardt, F | 1 |
| Chavez, CM; Conn, JH; Fain, WR | 1 |
| Babichev, VA; Levashev, VS; Pinegin, BV; Uteshev, BS | 1 |
| Matousek, V; Müllerova, M; Nouza, K; Pekárek, J; Svejcar, J; Trnka, L | 1 |
| Cassidy, EP; Fischer, DS; Welch, AD | 1 |
| Foley, GE; Lazarus, H | 1 |
| Lang, A; Nitsan, J | 1 |
| Miller, RW | 1 |
| Sirotnak, FM | 1 |
| Moeschlin, S | 1 |
| Fossati, C | 1 |
| Müllerová, M; Nouza, K; Trnka, L | 1 |
| Ambs, E; Heine, WD | 1 |
| Hunt, DE; Pittillo, RF | 1 |
| Hanka, LJ | 1 |
| Domenjoz, R; Knippertz, T; Mörsdorf, K; Rausch, KD | 1 |
| Bloch, A | 1 |
| Bishop, CF; Melnykovych, G | 1 |
| Sheremata, WA | 1 |
| Lee, HG; Michaels, RM | 1 |
| Carter, RF | 1 |
| Speirs, RS | 1 |
| Brody, S; Kumlien, A; Paul, KG | 1 |
| BUTLER, WT; COONS, AH | 1 |
| COLLIPP, PJ; KAPLAN, SA; PATRICK, JR | 1 |
| Bravo, D; Hahn, A; Houstava, L; Kalvach, P; Machová, H; Mandys, V; Marková, H; Otruba, L | 1 |
4 review(s) available for chloramphenicol and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Interaction of drugs and nutrition.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anticonvulsants; Avitaminosis; Chloramphenicol; Contraceptives, Oral; Cytochrome P-450 Enzyme System; Humans; Intestinal Absorption; Iodine; Iron; Methotrexate; Microsomes, Liver; Minerals; Mixed Function Oxygenases; Nutritional Physiological Phenomena; Pharmaceutical Preparations; Potassium; Protein-Energy Malnutrition; Tetrachloroethylene; Toxicology; Vitamins | 1977 |
[Liver damage due to drugs. I].
Topics: Arsenicals; Chemical and Drug Induced Liver Injury; Chloramphenicol; Cholestasis; Coumarins; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Halothane; Humans; Imipramine; Liver; Methotrexate; Methyldopa; Nicotinic Acids; Oxacillin; Phenylbutazone; Testosterone; Tetracycline | 1974 |
49 other study(ies) available for chloramphenicol and methotrexate
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The reversible inhibition of myoblast fusion by ethidium bromide (EB).
Topics: Cell Fusion; Cells, Cultured; Chloramphenicol; Cytarabine; DNA; Dose-Response Relationship, Drug; Ethidium; Floxuridine; Hydroxyurea; Methotrexate; Protein Biosynthesis; Rifampin; RNA; Thymidine | 1976 |
Osteogenic sarcoma in a patient with aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Bone Neoplasms; Chloramphenicol; Humans; Male; Methotrexate; Osteosarcoma; Prednisone; Testosterone | 1977 |
Drug interactions with antineoplastic agents.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Agents; Chloramphenicol; Cyclophosphamide; Drug Interactions; Drug Therapy, Combination; Fluorouracil; Humans; Mercaptopurine; Methotrexate; Mice; Neoplasms; Prednisolone; Rats; Thioguanine; Vinca Alkaloids | 1977 |
Vitamin B12 levels in drug-treated bacterial cells.
Topics: Bacillus megaterium; Chloramphenicol; Dactinomycin; Dose-Response Relationship, Drug; Fluorouracil; Methotrexate; Puromycin; Sulfathiazoles; Vitamin B 12 | 1975 |
[Hemopoietic disorder caused by drugs--special significance placed on anemia].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Megaloblastic; Anemia, Sideroblastic; Chloramphenicol; Ethanol; Humans; Methotrexate; Methyldopa; Middle Aged; Neomycin; Penicillins; Phenacetin; Phenobarbital | 1991 |
Induction of mitochondrial mutations in human cells by methotrexate.
Topics: Animals; Cell Line; Chloramphenicol; Cricetinae; DNA, Mitochondrial; Drug Resistance; Fibroblasts; Folic Acid Antagonists; HeLa Cells; Humans; Hybrid Cells; Kinetics; Methotrexate; Mutation; Thymidine Kinase; Thymidine Monophosphate | 1985 |
Acceleration of casein induced amyloidosis in mice by immunosuppressive agents.
Topics: Amyloid; Amyloidosis; Animals; Azathioprine; Busulfan; Caseins; Chloramphenicol; Cortisone; Dactinomycin; Daunorubicin; DNA; Female; Fluorouracil; Immunosuppressive Agents; Liver; Male; Mercaptopurine; Methotrexate; Mice; RNA; Spleen; Vinblastine | 1971 |
Continuous arterial infusion chemotherapy. Experience with 44 cases.
Topics: Adenocarcinoma; Arteries; Brain Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Catheterization; Chloramphenicol; Facial Neoplasms; Fever; Fluorouracil; Head and Neck Neoplasms; Humans; Infections; Infusions, Parenteral; Leucovorin; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Palliative Care; Penicillins; Stomach Neoplasms; Thoracic Neoplasms | 1967 |
[Effect of inhibitors of nucleinic, protein synthesis and cell division on primary immunologic response].
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Chloramphenicol; Colchicine; Depression, Chemical; DNA; Ethionine; Flavonoids; Fluorouracil; Methotrexate; Mice; RNA; Spleen | 1970 |
Immunosuppression and experimental tuberculosis. II. The effects of immunosuppressive agents and antilymphocyte serum on the organ dissemination of mycobacteria and on the development of specific delayed hypersensitivity.
Topics: Animals; Antigens, Bacterial; Antilymphocyte Serum; Azathioprine; Azauridine; Cell Migration Inhibition; Chloramphenicol; Cyclophosphamide; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Kidney; Liver; Lung; Methotrexate; Mice; Mycobacterium tuberculosis; Spleen; Tuberculosis; Virulence | 1974 |
Immunosuppression by pyrimidine nucleoside analogs.
Topics: Animals; Antibody Formation; Antimetabolites; Azathioprine; Bromodeoxyuridine; Chloramphenicol; Cytarabine; Cytosine Nucleotides; Erythrocytes; Floxuridine; Hemagglutination Tests; Idoxuridine; Injections, Intraperitoneal; Injections, Subcutaneous; Mercaptoethanol; Mercaptopurine; Methotrexate; Mice; Nucleosides; Sheep | 1966 |
The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agents.
Topics: Animals; Azaserine; Chloramphenicol; Culture Media; Culture Techniques; Cyclophosphamide; Cytarabine; Dactinomycin; Deoxyuridine; Floxuridine; Fluorouracil; Humans; Hydrocortisone; Lymphocytes; Mechlorethamine; Mercaptopurine; Methotrexate; Mitomycins; Puromycin; Thymidine; Triazines; Vincristine | 1967 |
Relations among cell growth, DNA synthesis, and gibberellin action.
Topics: Carbon Isotopes; Chloramphenicol; Dactinomycin; DNA; Ethanol; Floxuridine; Gibberellins; Methotrexate; Mitomycins; Plants, Edible; Puromycin; RNA; Thymidine; Tritium; Uridine | 1967 |
Transplacental chemical carcinogenesis in man.
Topics: Abnormalities, Drug-Induced; Aminopterin; Animals; Chloramphenicol; Diethylstilbestrol; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Maternal-Fetal Exchange; Methotrexate; Mice; Neoplasms; Neoplasms, Muscle Tissue; Phenytoin; Pregnancy; Uterine Cervical Neoplasms; Vaginal Neoplasms | 1971 |
High dihydrofolate reductase levels in Diplococcus pneumoniae after mutation in the structural gene: biochemical and immunological evidence for increased synthesis.
Topics: Animals; Antigens, Bacterial; Bacterial Proteins; Carbon Isotopes; Chloramphenicol; Chromosome Mapping; Drug Resistance, Microbial; Female; Folic Acid; Genes; Genetics, Microbial; Hydrogen-Ion Concentration; Immune Sera; Immunodiffusion; Methotrexate; Mutation; Neutralization Tests; Phenylalanine; Precipitin Tests; Rabbits; Recombination, Genetic; Spectrophotometry; Streptococcus pneumoniae; Tetrahydrofolate Dehydrogenase; Transformation, Genetic | 1971 |
[Treatment of autoimmune diseases].
Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Blood Protein Disorders; Child, Preschool; Chloramphenicol; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Drug Synergism; Female; Hepatitis; Humans; Immunosuppressive Agents; Long-Term Care; Lupus Vulgaris; Male; Methotrexate; Middle Aged; Nephrosis, Lipoid; Pemphigus; Polyarteritis Nodosa; Postoperative Complications; Purpura, Thrombocytopenic; Scleroderma, Systemic; Transplantation, Homologous | 1971 |
Immunosuppression and experimental tuberculosis. I. The effects of immunosuppressive agents, antilymphocyte serum and antimacrophage serum on the survival of animals with subacute experimental tuberculosis.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Azauridine; Chloramphenicol; Cyclophosphamide; Female; Hydrocortisone; Immunosuppressive Agents; Methotrexate; Mice; Time Factors; Tuberculosis | 1973 |
[Generalized reticulosis in an 11 months old boy (author's transl)].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Autopsy; Bone Marrow; Central Nervous System; Child, Preschool; Chloramphenicol; Humans; Infant; Kidney; Liver; Lymph Nodes; Lymphatic Diseases; Male; Meninges; Mercaptopurine; Methotrexate; Reticulocytes; Skin Manifestations; Spleen; Vincristine | 1974 |
Killing of cells in bacterial colonies.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Azaserine; Chloramphenicol; Enterococcus faecalis; Escherichia coli; Fluorouracil; Kinetics; Methotrexate; Nitroso Compounds; Penicillin G; Urea | 1967 |
Microbiological assay for cytosine arabinoside (NSC-63878) in biologic materials containing other antitumor or antibacterial drugs.
Topics: Ampicillin; Biological Assay; Cephalothin; Chloramphenicol; Cytarabine; Dactinomycin; Depression, Chemical; Drug Antagonism; Enterococcus faecalis; Erythromycin; Leucovorin; Lincomycin; Methods; Methotrexate; Nucleosides; Penicillins; Tetracycline | 1971 |
Studies on the antiphlogistic activity of cytostatics.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites; Carrageenan; Chloramphenicol; Cyclophosphamide; Dextrans; Edema; Fluorouracil; Foot; Hydrolysis; Indomethacin; Inflammation; Leukocyte Count; Male; Methotrexate; Penicillamine; Phenylbutazone; Rats; Triaziquone | 1972 |
Induction of the dihydrofolate reductase of Streptococcus faecium var. Durans by folic acid and by some of its derivatives.
Topics: Cell-Free System; Chemical Phenomena; Chemistry; Chloramphenicol; Culture Media; Dactinomycin; Enzyme Induction; Folic Acid; Leucovorin; Methotrexate; Purines; Streptococcus; Tetrahydrofolate Dehydrogenase; Thymine; Time Factors | 1970 |
Specific binding of cortisol in subcellular fractions of HeLa cells: temperature dependence and effects of inhibitors.
Topics: 17-Hydroxycorticosteroids; Arsenicals; Azides; Binding Sites; Cell Nucleus; Chloramphenicol; Cyanides; Cycloheximide; Cytoplasm; Dactinomycin; Depression, Chemical; Dinitrophenols; Female; Fluorouracil; HeLa Cells; Hexoses; Humans; Hydrocortisone; In Vitro Techniques; Iodoacetates; Methotrexate; Microsomes; Mitochondria; Ouabain; Prednisolone; Puromycin; Temperature; Tritium | 1971 |
Reiter's disease. A case with severe and unusual complications.
Topics: Adult; Arthritis, Reactive; Chloramphenicol; Hemorrhagic Disorders; Humans; Male; Methotrexate; Neurologic Manifestations | 1967 |
In vitro and in vivo effects of selected metabolic inhibitors and chemotherapeutic agents on adults and egg development of Schistosoma mansoni.
Topics: Animals; Anthelmintics; Azoles; Chloramphenicol; Dactinomycin; Female; Methotrexate; Mice; Ovum; Puromycin; Schistosoma; Schistosomiasis; Snails; Tartrates | 1968 |
Sensitivity to amphotericin B of a Naegleria sp. isolated from a case of primary amoebic meningoencephalitis.
Topics: Amebiasis; Amoeba; Amphotericin B; Animals; Chloramphenicol; Emetine; Humans; Meningoencephalitis; Methotrexate; Metronidazole; Mice; Oxytetracycline; Penicillins; Quinine; Streptomycin; Sulfadiazine | 1969 |
Examination of the mechanism of antibody formation using nucleic acid and protein inhibitors.
Topics: Animals; Antibody Formation; Blood; Chloramphenicol; Dactinomycin; Erythromycin; Immune Tolerance; In Vitro Techniques; Methotrexate; Mice; Puromycin; RNA, Messenger; Streptomycin; Tetanus Toxoid | 1965 |
Studies on eosinophil granulocytes. II. The effect of cytostatics on the uterine response to oestrogen.
Topics: Animals; Castration; Catalase; Chloramphenicol; Eosinophils; Estrogens; Female; Fluorouracil; Liver; Mercaptopurine; Methotrexate; Mice; Organ Size; Peroxidases; Pyridoxine; Streptomycin; Triazoles; Uterus | 1966 |
STUDIES ON ANTIBODY PRODUCTION. XII. INHIBITION OF PRIMING BY DRUGS.
Topics: Animals; Antibody Formation; Antineoplastic Agents; Antiprotozoal Agents; Azaguanine; Chloramphenicol; Chlorpromazine; Colchicine; Dactinomycin; Edetic Acid; Hydrocortisone; Immunization; Mercaptopurine; Methotrexate; Mice; Pharmacology; Quinolines; Research; Thiotepa; Vaccination | 1964 |
REDUCED LIVER GLUCOSE-6-PHOSPHATASE IN HUMAN LEUKEMIA.
Topics: Antineoplastic Agents; Child; Chloramphenicol; Clinical Enzyme Tests; Dactinomycin; Drug Therapy; Glucose-6-Phosphatase; Humans; Leukemia; Liver; Mercaptopurine; Methotrexate; Penicillins; Prednisone; Toxicology; Vincristine | 1965 |
Mastoiditis complicated with Gradenigo syndrome and a hypertrophic pachymeningitis with consequent communicating hydrocephalus.
Topics: Abducens Nerve Diseases; Anti-Bacterial Agents; Ceftriaxone; Cerebrospinal Fluid; Chloramphenicol; Drug Therapy, Combination; Humans; Hydrocephalus; Hypertrophy; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mastoiditis; Meninges; Meningitis; Methotrexate; Methylprednisolone; Middle Aged; Otitis Media; Petrous Bone; Syndrome; Trigeminal Nerve Diseases | 2007 |